Patents by Inventor Sean Mackay

Sean Mackay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12259392
    Abstract: Disclosed are methods of identifying a secretome from a subject cell within a heterogeneous cell population when the subject cell contacts a target cell (e.g. a subject immune cell contacts a target cancer cell) or a stimulatory agent and methods of using the identified secretome to identify cells that are safe and efficacious for cellular therapies, including adoptive CAR T-cell therapies.
    Type: Grant
    Filed: March 9, 2023
    Date of Patent: March 25, 2025
    Assignee: IsoPlexis Corporation
    Inventors: Sean Mackay, Colin Ng, Emily Bettini
  • Patent number: 12180531
    Abstract: Embodiments disclose apparatus, methods and software for performing biological screening and analysis implemented using an instrument platform capable of detecting a wide variety of cell-based secretions, expressed proteins, and other cellular components. The platform may be configured for simultaneous multiplexed detection of a plurality biological components such that a large number of discrete samples may be individually sequestered and evaluated to detect or identify constituents from the samples in a highly parallelized and scalable manner.
    Type: Grant
    Filed: December 23, 2022
    Date of Patent: December 31, 2024
    Assignee: IsoPlexis Corporation
    Inventors: Patrick Paczkowski, Sean Mackay, Sean Mccusker
  • Patent number: 12139748
    Abstract: Disclosed are compositions and methods for the multiplexed analysis of one or more intracellular targets of a single cell. Exemplary compositions of the disclosure comprise a surface comprising a plurality of capture agents operatively-linked thereto, wherein each capture agent specifically binds to a distinct intracellular target and wherein the plurality of capture agents form a repeating pattern; a substrate comprising a plurality of chambers, wherein the substrate releasably couples with the surface and wherein each chamber of the plurality of chambers comprises at least one repeat of the repeating pattern of the plurality of capture agents of the surface; a coating composition comprising a cell lysis composition; and a linker composition comprising a functionalization component and an extension component.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: November 12, 2024
    Assignee: IsoPlexis Corporation
    Inventors: Colin Ng, Alaina Kaiser, Emily Bettini, Patrick Paczkowski, Sean MacKay, Feimei Liu, Maithreyan Srinivasan
  • Patent number: 11812760
    Abstract: A method for roasting coffee beans comprising the steps of a) heating the coffee beans until the temperature of the coffee beans is at least 180° C.; b) injecting a stream of oxygen-containing gas into the flow of hot air after the burner; and c) maintaining the injection of the stream of oxygen-containing gas until the end of the roasting process to mitigate the concentration of carbon monoxide in the roasting chamber, and wherein the coffee beans are roasted in a rotating fluidized bed roaster.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: November 14, 2023
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Kevan Arthur Elsby, Sean Mackay Murphy
  • Patent number: 11661619
    Abstract: Embodiments disclose apparatus, methods and software for performing biological screening and analysis implemented using an instrument platform capable of detecting a wide variety of cell-based secretions, expressed proteins, and other cellular components. The platform may be configured for simultaneous multiplexed detection of a plurality biological components such that a large number of discrete samples may be individually sequestered and evaluated to detect or identify constituents from the samples in a highly parallelized and scalable manner.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: May 30, 2023
    Assignee: IsoPlexis Corporation
    Inventors: Patrick Paczkowski, Sean Mackay, Sean McCusker
  • Patent number: 11525783
    Abstract: Embodiments of the current disclosure are directed to systems, methods and apparatus for evaluating single cell secretion profiles. In some embodiments, the apparatus may be configured to analyze substances expressed by a biological cell and may include a first compressible substrate, and a second substrate configured for removable sealing attachment with the first substrate. In some embodiments, upon attachment of the second substrate with the first substrate, an assembly is formed such that the open side of the plurality of chambers are covered by the second substrate, and a portion of each of the plurality of capture areas are exposed in each of the chambers.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: December 13, 2022
    Assignee: IsoPlexis Corporation
    Inventors: Peter Tsiomplikas, Jerry Sedgewick, Jeffrey Whynall, Sean MacKay, Colin Ng, Patrick Paczkowski, Sean McCusker, Igor Nikonorov, Alaina Kaiser
  • Patent number: 11493508
    Abstract: Disclosed are compositions and methods for the multiplexed analysis of one or more intracellular targets of a single cell. Exemplary compositions of the disclosure comprise a surface comprising a plurality of capture agents operatively-linked thereto, wherein each capture agent specifically binds to a distinct intracellular target and wherein the plurality of capture agents form a repeating pattern; a substrate comprising a plurality of chambers, wherein the substrate releasably couples with the surface and wherein each chamber of the plurality of chambers comprises at least one repeat of the repeating pattern of the plurality of capture agents of the surface; a coating composition comprising a cell lysis composition; and a linker composition comprising a functionalization component and an extension component.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: November 8, 2022
    Assignee: IsoPlexis Corporation
    Inventors: Colin Ng, Alaina Kaiser, Emily Bettini, Patrick Paczkowski, Sean Mackay, Feimei Liu, Maithreyan Srinivasan
  • Publication number: 20220232847
    Abstract: The present invention relates to a coffee composition with improved aroma and a method of producing a coffee composition wherein two different types of coffee beans are roasted separately.
    Type: Application
    Filed: April 1, 2020
    Publication date: July 28, 2022
    Inventors: Kevan Arthur Elsby, Christian Milo, Sean Mackay Murphy, Luigi Poisson, Tomas Davidek, Stefan Spreng
  • Patent number: 11066689
    Abstract: Embodiments disclose apparatus, methods and software for performing biological screening and analysis implemented using an instrument platform capable of detecting a wide variety of cell-based secretions, expressed proteins, and other cellular components. The platform may be configured for simultaneous multiplexed detection of a plurality biological components such that a large number of discrete samples may be individually sequestered and evaluated to detect or identify constituents from the samples in a highly parallelized and scalable manner.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: July 20, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Patrick Paczkowski, Sean MacKay, Sean McCusker
  • Publication number: 20200187518
    Abstract: A method for roasting coffee beans comprising the steps of a) heating the coffee beans until the temperature of the coffee beans is at least 180° C.; b) injecting a stream of oxygen-containing gas into the flow of hot air after the burner; and c) maintaining the injection of the stream of oxygen-containing gas until the end of the roasting process to mitigate the concentration of carbon monoxide in the roasting chamber, and wherein the coffee beans are roasted in a rotating fluidized bed roaster.
    Type: Application
    Filed: June 11, 2018
    Publication date: June 18, 2020
    Inventors: Kevan Arthur Elsby, Sean Mackay Murphy
  • Patent number: 10584366
    Abstract: Embodiments disclose apparatus, methods and software for performing biological screening and analysis implemented using an instrument platform capable of detecting a wide variety of cell-based secretions, expressed proteins, and other cellular components. The platform may be configured for simultaneous multiplexed detection of a plurality biological components such that a large number of discrete samples may be individually sequestered and evaluated to detect or identify constituents from the samples in a highly parallelized and scalable manner.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: March 10, 2020
    Assignee: IsoPlexis Corporation
    Inventors: Patrick Paczkowski, Sean MacKay, Sean McCusker
  • Publication number: 20070265043
    Abstract: An integrated on-line networked video game system is disclosed. Effects of variable latency are mitigated dynamically to assure that all players see game displays consistent with actual game actions. Games are organized into events that allow dynamic enhancement of character capabilities during play.
    Type: Application
    Filed: April 11, 2007
    Publication date: November 15, 2007
    Inventors: Andy Wang, Gabriel Law, Sean Mackay
  • Publication number: 20040071323
    Abstract: A system for monitoring the execution of a procedure within a predetermined environment comprising means for recording characteristics of the procedure during the time in which the procedure is executed. These can be video, audio, or other data characteristics of the procedure and can be subsequently be accessed for review.
    Type: Application
    Filed: November 24, 2003
    Publication date: April 15, 2004
    Inventors: Ara Warkes Darzi, Lee David Edwards, Sean Mackay, Edward Draper
  • Patent number: 5853788
    Abstract: A flowable roasted and ground coffee product is provided having a median volumetric ("X50") particle size of from 270 to 1100 .mu.m, a density of from 0.5 to 0.7 gm/cc and 30-41% by weight of which extracts when brewed. The product is in the form of aggregates of granular roasted and ground coffee particles having a maximum X50 particle size of 270 .mu.m and is produced by forcing roasted and ground or roasted whole bean coffee through an orifice under conditions of pressure and shear sufficient to grind the coffee and to form the coffee into a dense mass of roasted coffee made up of the granular roasted and ground coffee particles tightly bonded together. The dense mass of roasted coffee is then reground to produce the roasted and ground coffee product which is in the form of aggregates having an X50 particle size in the range of 270-1100 .mu.m, the aggregates being made up of the granular coffee particles.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: December 29, 1998
    Assignee: Kraft Foods, Inc.
    Inventors: Sean Mackay Murphy, Helmut Sieling, Gerald Sigmund Wasserman
  • Patent number: 5725898
    Abstract: A flowable roasted and ground coffee product is provided having a median volumetric ("X50") particle size of from 270 to 1100 .mu.m, a density of from 0.5 to 0.7 gm/cc and 30-41% by weight of which extracts when brewed. The product is in the form of aggregates of granular roasted and ground coffee particles having a maximum X50 particle size of 270 .mu.m and is produced by forcing roasted and ground or roasted whole bean coffee through an orifice under conditions of pressure and shear sufficient to grind the coffee and to form the coffee into a dense mass of roasted coffee made up of the granular roasted and ground coffee particles tightly bonded together. The dense mass of roasted coffee is then reground to produce the roasted and ground coffee product which is in the form of aggregates having an X50 particle size in the range of 270-1100 .mu.m, the aggregates being made up of the granular coffee particles.
    Type: Grant
    Filed: April 24, 1996
    Date of Patent: March 10, 1998
    Assignee: Kraft Foods, Inc.
    Inventors: Sean Mackay Murphy, Helmut Sieling, Gerald Sigmund Wasserman